Skyleap Life Science Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 31-05-2024
- Paid Up Capital ₹ 0.10 M
as on 31-05-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2020)
- Profit -188.18%
(FY 2020)
- Ebitda -282.27%
(FY 2020)
- Net Worth -83.67%
(FY 2020)
- Total Assets 57.66%
(FY 2020)
About Skyleap Life Science Technologies
The Company is engaged in the Education & Learing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sumedh Ramteke, Nitin Wakode, and Suman Meshram serve as directors at the Company.
- CIN/LLPIN
U80903PN2018PTC179225
- Company No.
179225
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Sep 2018
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Skyleap Life Science Technologies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumedh Ramteke  | Director | 29-Sep-2018 | Current |
| Nitin Wakode | Director | 29-Sep-2018 | Current |
| Suman Meshram | Director | 29-Sep-2018 | Current |
Financial Performance of Skyleap Life Science Technologies.
Skyleap Life Science Technologies Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 188.18% decrease in profit. The company's net worth observed a substantial decline by a decrease of 83.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Skyleap Life Science Technologies?
Unlock access to Skyleap Life Science Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Skytronics Infotech Private LimitedActive 5 years 8 months
Sumedh Ramteke and Nitin Wakode are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Skyleap Life Science Technologies?
Unlock and access historical data on people associated with Skyleap Life Science Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skyleap Life Science Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skyleap Life Science Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
